BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11113073)

  • 1. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Nakamaru K; Okamoto M; Naganuma M; Ishii H; Ikeda M; Kurimoto M; Hibi T
    Gastroenterology; 2000 Dec; 119(6):1514-23. PubMed ID: 11113073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
    Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
    Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 and Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Hibi T
    Digestion; 2001; 63 Suppl 1():37-42. PubMed ID: 11173908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
    J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
    Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
    Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive IL-18 expression is up-regulated in Crohn's disease.
    Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
    J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
    Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
    Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
    Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
    Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease.
    Salvati VM; MacDonald TT; Bajaj-Elliott M; Borrelli M; Staiano A; Auricchio S; Troncone R; Monteleone G
    Gut; 2002 Feb; 50(2):186-90. PubMed ID: 11788557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa.
    Watanabe M; Ueno Y; Yajima T; Okamoto S; Hayashi T; Yamazaki M; Iwao Y; Ishii H; Habu S; Uehira M; Nishimoto H; Ishikawa H; Hata J; Hibi T
    J Exp Med; 1998 Feb; 187(3):389-402. PubMed ID: 9449719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease.
    Monteleone G; Monteleone I; Fina D; Vavassori P; Del Vecchio Blanco G; Caruso R; Tersigni R; Alessandroni L; Biancone L; Naccari GC; MacDonald TT; Pallone F
    Gastroenterology; 2005 Mar; 128(3):687-94. PubMed ID: 15765404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
    Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
    Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 and Mucosal CD14+ Monocyte-Like Cells Induce IL-8 in Colonic Memory CD4+ T Cells of Patients With Ulcerative Colitis but not Crohn's Disease.
    Chapuy L; Bsat M; Rubio M; Sarkizova S; Therrien A; Bouin M; Orlicka K; Weber A; Soucy G; Villani AC; Sarfati M
    J Crohns Colitis; 2020 Jan; 14(1):79-95. PubMed ID: 31206576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.
    Camoglio L; Te Velde AA; Tigges AJ; Das PK; Van Deventer SJ
    Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.